Elanco Animal Health Incorporated (ELAN) NYSE
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In USD
Address
2500 Innovation Way
Greenfield, IN 46140
United States of America (the)
Phone
877 352 6261
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
9000
First IPO Date
September 20, 2018
| Name | Title | Pay | Year Born |
| Jeffrey N. Simmons | President, Chief Executive Officer & Director | 2.93M | 1967 |
| David S. Kinard | Executive Vice President of Human Resources, Corporate Communications & Administration | 722,576 | 1967 |
| Timothy J. Bettington | Executive Vice President of Center of Strategic Growth | 1.18M | 1974 |
| Ramiro Martin Cabral | Executive Vice President & President of Elanco International | 1.24M | 1972 |
| Ellen de Brabander | Executive Vice President of Research, Development & Regulatory Affairs | 1.62M | 1963 |
| Robert VanHimbergen | Executive Vice President & Chief Financial Officer | 1.83M | 1976 |
| James Meer | Senior Vice President & Chief Accounting Officer | 0 | 1970 |
| Larbi Van Lier | Senior Vice President of Asia | 0 | N/A |
| Shiv O'Neill | Executive Vice President, General Counsel & Corporate Secretary | 0 | 1975 |
| Tiffany Ann Kanaga | Vice President of Investor Relations & ESG | 0 | N/A |
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.